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Abstract
Purpose The aim of the present study was to evaluate the
clinical and radiographic results of primary total hip
arthroplasty (THA) performed with the Alloclassic Variall
system (a modified version of the Alloclassic Zweymüller
system) and to compare them with those in the literature for
the original system.
Methods Between January 2001 and December 2002, 273
consecutive primary THAs were performed in 259 patients
at a single centre with the study system, using ceramic-on-
ceramic (81.7 %) or ceramic-on-highly-crosslinked-
polyethylene (18.3 %) articulations.
Results At the time of this study, 28 patients (29 hips; 10.6 %)
had died and 40 (43 hips; 15.8 %) were lost to follow-up.
Seventeen patients (19 hips; 7.0 %) could be reached only
by telephone. There were four revisions in four patients
(1.5 %), all involving only the femoral component. Ten-year
Kaplan-Meier survival with revision of any component for
any reason as the endpoint was 98.4 % (95 % confidence
interval: 96.9–100 %; 30 hips remained ‘at risk’). A total of
170 unrevised patients (178 hips; 65.2 %) were assessed clin-
ically and radiographically at a median follow-up of 9.3 years
(interquartile range [IQR] 8.8–9.8 years). The median Harris
hip score (HHS) was 99.9 points (IQR 97.7–100). The score
did not differ significantly between the two articulations.
There was no sign of radiographic loosening.
Conclusions The ten-year implant survival and the HHS score
outcomes for THAs performed with the novel system were in
line with those documented in the literature for its predecessor.
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Introduction
The Alloclassic Zweymüller hip system (Zimmer GmbH,
Winterthur, CH) was introduced in 1979 for patients undergo-
ing total hip arthroplasty (THA) [1]. The system includes: the
Alloclassic Zweymüller stem, a straight tapered titanium alloy
stem with a rectangular cross-section; and the Alloclassic
Zweymüller conical self-tapping cement-free (CSF) cup, a
conically shaped titanium shell with sharp self-tapping blades
(i.e. a screw shell design) that combines with either a polyeth-
ylene (PE) insert or a sandwich insert made of PE/Wrought-
Forged-CoCrMo (Metasul, Zimmer GmbH) (Fig. 1). The sys-
tem has been modified several times, but without changing its
design philosophy [1].
In the late 1990s, the Alloclassic Variall system (Zimmer
GmbH) was developed from the original system. Unlike the
original stem, the proximal part of the novel stem has an
additional surface macrostructure, with grooves. This in-
creases the intertrochanteric initial press-fit [2], while enlarg-
ing the contact area between new-formed bone and the stem to
enhance secondary stability. Unlike the original shell, the nov-
el shell has a spherical base [3], rather than sharp edges, to
reduce the risk of bone perforation. In addition, the novel shell
can also be combined with ceramic inserts.
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Although many studies have documented mid to long-term
clinical outcomes with the original system [4–12], only a few
have been published on the novel system [2, 3, 13]. To aid
healthcare decision-making, we reviewed the results of THAs
performed with the novel system at a single centre, and com-
pared these results with those reported in the literature for the
original stem.
Materials and methods
In 2011, using the hip arthroplasty register of St.Vincent`s
Hospital, Linz, Austria, all patients who underwent THAwith
the study device, using either ceramic-on-ceramic (CoC) or
ceramic-on-highly-crosslinked-polyethylene (CoPE) articula-
tions, between January 2001 and December 2002 were
selected to constitute the study cohort.
The cohort comprised 259 consecutive patients (273
THAs), of whom 93 were men (35.9 %) and 166 women
(64.1 %), at a median age of 65 years at the time of surgery
(IQR 52–72 years). Indications for surgery were: primary os-
teoarthritis in 209 cases (76.6 %), osteonecrosis of the femoral
head in 31 cases (11.4 %), developmental hip dysplasia in 30
cases (11.0 %) and fracture of the femoral neck in three cases
(1.1 %) (Table 1).
Operative information
All THAs were performed using the lateral approach, with the
patients placed in supine position [14, 15]. The acetabular
shell was screwed into the acetabulum; with optimal orienta-
tion considered to be an anteversion angle of 10–15° and an
inclination angle of 40–45°. The shells were combined with
ceramic inserts (BIOLOX forte, CeramTecGmbH, DE) in 223
cases (81.7 %), and with highly-crosslinked-PE (Durasul,
Zimmer GmbH) inserts in the remaining 50 cases (18.3 %).
28 mm ceramic femoral heads (BIOLOX forte, CeramTec
GmbH, DE) were implanted in all hips.
All patients were asked to return for a follow-up visit to
assess implant survival, the incidence and nature of any ad-
verse events, and clinical and radiographic outcomes at ap-
proximately ten years after surgery.
Clinical outcome assessment
Harris hip score (HHS) was assessed at follow-up in 2011 for
unrevised patients. The results were classified as: excellent
(90–100), good (80–89), fair (70–79) or poor (<70).
Radiographic assessment
Hip anteroposterior (AP) view radiographs obtained in the
immediate post-operative period and at the final follow-up in
2011 were analysed by one of the authors (KE). The following
parameters were assessed: femoral and acetabular radiolucent
lines, femoral bone hypertrophy, heterotopic ossification, stem
subsidence and change in orientation of the cup.
Fig. 1 Alloclassic Variall stem and Alloclassic Variall shell
Table 1 Characteristics of the 259 patients (273 hips) in the initial
cohort
Demographic information Value
Number of hips (number of pts) 273 (259)
Gender (number of hips, % / N° of pts, %)
Male 98 (35.9 %) / 93 (35.9 %)
Female 175 (64.1 %) / 166 (64.1 %)
Side (number of hips, %)
Left hip 131 (48.0 %)
Right hip 142 (52.0 %)
Age at surgery [years]
Mean±SD / (range) 64±11 / (28–86)
Median / (IQR) 65 / (57–72)
Distribution Ν
Pre-op diagnosis (number of hips, %)
Primary osteoarthritis 209 (76.6 %)
Osteonecrosis of the femoral head 31 (11.4 %)
Developmental dysplasia 30 (11.0 %)
Femoral neck fracture 3 (1.1 %)
Implanted prosthesis information
Shell diameter [mm]
Most used / (range) 48 / (44–58)
Head diameter [mm]
Most used / (range) 28 / (28–28)
Stem size
most used / (range) 5 / (1–9)
Femoral neck offset
(% of hips with: s / m / l / xl offset) 17.6 % / 40.7 % / 41.4 % / 0.4 %
Bearing type (number of hips, %)




BΝ^ indicates that the values are not normally distributed, based on the
Shapiro-Wilk test
IQR interquartile range, pts patients
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Radiolucent lines are lower bone density lines around the
implant, at the interface between the bone and the prosthesis.
Bone hypertrophy is an area of greater bone density than the
surroundings. Radiolucent lines and hypertrophy were
assessed with reference to the seven zones defined by Gruen
et al. [16] for the femoral component and with reference to the
three DeLee and Charnley areas [17] for the acetabular com-
ponent. Heterotopic ossification was classified using the
criteria set out by Brooker et al. [18]. Stem subsidence was
defined as downward axial stem migration relative to the po-
sition documented in the first post-operative radiograph. Only
stem subsidence of ≥5 mmwas considered [19]. According to
Engh et al. [20], femoral stems were regarded as radiograph-
ically loose when there was a progressive subsidence or a
progressive widening of radiolucent lines; acetabular shells
were considered as radiographically loose when there was
progressive widening of radiolucent lines or a change in
inclination.
Statistical analysis
Categorical data were summarized using counts and percent-
ages. Continuous data were expressed as mean, standard de-
viation (SD), median and IQR. The Shapiro-Wilk test was
used to test for normality.
Comparison between groups (i.e. CoC THA vs. CoPE
THA)was performed using Student's t-test in case of normally
distributed continuous data, or using Mann–Whitney U-test
for non-parametric analysis, while proportions were compared
by chi-squared test or by Fisher’s exact test, as appropriate. A
p-value of <0.05 was considered to indicate statistical
significance.
Survival rates at ten years were calculated using Kaplan-
Meier survival analysis with 95 % confidence intervals. The
following endpoints were considered: stem revision for any
reason, cup (i.e. shell and/or insert) revision for any reason and
revision of any component for any reason. Patients who had
died or who were lost-to-follow-up were censored at the time
of the last available information on their implant status. The
statistical analysis was performed using IBM SPSS 21 (IBM
Corp.).
Ethical approval
This study was approved by the Ethics Committee of the
Institution. Informed consent was obtained from all individual
participants included in the study.
Results
At the time of final review, 170 (178 THAs) patients from the
original 259 (273 THAs) were assessed both clinically and
radiographically at a median follow-up of 9.3 years (IQR
8.8–9.8 years). Of the other patients, 28 (29 THAs) had died,
40 (43 THAs) were lost to follow-up and four (four THAs)
had undergone hip revision. Finally, 17 patients (19 THAs)
underwent only a telephone interview as they were unable to
attend hospital due to distance or poor general condition
(Fig. 2). None had undergone revision surgery, and the date
of the phone call was considered in the survival rate
calculation.
Among the four revisions, two femoral stems were revised
due to periprosthetic fracture two weeks and two months after
implantation, respectively. One femoral stem was revised five
months after implantation due to significant subsidence. The
stem had not osseointegrated, and it was considered under-
sized and was replaced by a larger stem. One stemwas revised
6.3 years after implantation due to aseptic loosening (i.e. ra-
diographic signs of loosening and pain). Intra-operatively the
implant was found to be definitely loose.
There were also four intra-operative fractures of the greater
trochanter, with cranial dislocation of the fractured fragment.
They were successfully treated intra-operatively with cerclage
wires. No other complications were documented.
Ten-year Kaplan-Meier survival was 100 % (with 30 hips
remaining ‘at risk’), with cup revision for any reason as the
endpoint, and 98.4 % (95 % CI 96.9–100 %; with 30 hips
remaining ‘at risk’), with stem revision for any reason or any
component revision for any reason as the endpoints (Fig. 3).
Clinical outcome assessment
The median HHS for the 170 unrevised patients (178 hips)
who attended the last visit was 99.9 (IQR 97.7–100) (Table 2).
The score was categorized as excellent or good in 174 cases
(97.8 %) and fair in one case (0.6 %), while the results were
poor in three cases (1.7 %). The poor HHS results in these
three cases were mainly due to comorbidities (i.e. patient af-
fected by spinal or contralateral hip disorders).
The HHS results did not significantly differ between the
CoC and CoPE articulations (p=0.254).
Radiological outcomes
Radiolucent lines around the stem in at least one Gruen zone
were detected in 12 hips (6.7 % of the hips that could be
assessed radiographically; see Fig. 4). The highest incidence
was in zone 7 (ten hips; 5.6 %). No radiolucent lines were
observed in zones 4, 5 and 6. Radiolucent lines around the
acetabular shell were detected only in one hip in zone III
(0.6 %). There were no radiolucent lines larger than 2 mm.
Femoral bone hypertrophy around the stem was detected in
five hips (2.8 % of the hips that could be assessed radiograph-
ically) in zone 3 (one hip), zone 4 (one hip), zone 5 (three hips)
and zone 7 (one hip). None of the unrevised hips had stem
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subsidence or any other signs of stem or cup loosening at final
follow-up. Heterotopic ossification was detected in 42 hips
(23.6 %) and classified as grade I in 29 hips (16.3 %), grade
II in 12 hips (6.7 %) and grade III in one hip (0.6 %). No hip
had heterotopic ossification grade IV. The percentage of pa-
tients with heterotopic ossification was smaller in the group
who received non-steroidal anti-inflammatory drugs
(NSAIDs) than in those who received opioids or no medica-
tion (20.3 % versus 44.0 %; p=0.010; chi-square test).
Discussion
The survival/revision rate is one of the most important param-
eters to consider when evaluating THA outcomes [9]. In our
series we documented ten-year Kaplan-Meier survival of
98.4 % (95 % CI 96.6–100 %) with stem revision and any
component revision as the endpoints, and 100 % with cup
revision as the endpoint. We compared our results with those
of published studies on the original system in primary THA as
Fig. 3 Kaplan-Meier survival
analysis with 95 % confidence
interval (CI), considering revision
of any component for any reason
as the endpoint. The ten-year
survival was estimated at 98.4 %
(95 % CI 96.9–100 %; 30 hips
remaining ‘at risk’)
Fig. 2 Distribution of total hip
arthroplasties. FUP follow-up
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summarized in Table 3 [4, 6–12]. In these studies, the ten-year
Kaplan-Meier survival rates range from 98.9 % to 100 % for
the stem [7–9, 11], from 93 % to 99 % for the cup [7, 9, 11]
and from 92 % to 98 % for the entire system (i.e. any compo-
nent revision as endpoint) [4, 6, 7, 9–12].
Additionally, we analysed the review article by Janda et al.
[1], which summarizes systematically searched published
studies on THAs performed with the original system. The
authors focused their statistical analysis not on KM survival,
but on a parameter called ‘revisions per 100 observed compo-
nent years’. This parameter allows to pool together data from
different cohorts and to calculate an overall Brevision rate^.
All the patients in the initial cohort are taken into consider-
ation until the time of the latest follow-up or death. For THAs
performed with the original system, Janda et al. documented
0.27 revisions per 100 observed component years (95 % CI
0.20–0.37). This value was based on a pooled cohort of 1,760
THAs with a mean implantation time per THA of 8.69 years.
Fig. 4 Distribution at final follow-up of femoral and acetabular radiolucent lines and femoral bone hypertrophy (based on the Gruen zones and the
DeLee and Charnley areas) for the 178 unrevised hips
Table 2 Harris hip score results at final follow-up for the entire cohort and for the two articulation sub-cohorts
Group All Ceramic-on-ceramic (CoC) Ceramic on highly-crosslinked-PE (CoPE) p-value (CoC vs CoPE)
Number of hips 178 151 27 N/A
Follow-up time [years]
Mean±SD / (range) 9.3±0.5 / (8.4 - 10.3) 9.4±0.5 / (8.4 - 10.3) 8.9±0.3 / (8.5 - 9.9) p<0.001a
Median / (IQR) 9.3 / (8.8 - 9.8) 9.5 / (9.0 - 9.8) 8.8 / (8.6 - 9.0)
Distribution Ν Ν Ν
Age at follow-up [years]
Mean±SD / (range) 72±10 / (37–91) 71±10 / (37–91) 75±9 / (58–86) p=0.098a
Median / (IQR) 73 / (65–80) 73 / (65–79) 76 / (67–83)
Distribution Ν Ν Ν
Harris hip score: total
Mean±SD / (range) 97.4±6.1 / (55–100) 97.2±6.4 / (55–100) 98.4±4.0 / (80–100) p=0.254a
median / (IQR) 99.9 / (97.7 - 100) 99.9 / (97.7 - 100) 100 / (97.9 - 100)
Distribution Ν Ν Ν
Harris hip score: result classification (number of hips, %)
Excellent (90–100 pts) 163 (91.6 %) 137 (90.7 %) 26 (96.3 %) Excellent+Good vs
Fair+Poor
(97.4 % vs 100 %)
p=1.000b
Good (80–89 pts) 11 (6.2 %) 10 (6.6 %) 1 (3.7 %)
Fair (70–79 pts) 1 (0.6 %) 1 (0.7 %) 0
Poor (<70 pts) 3 (1.7 %) 3 (2.0 %) 0
IQR interquartile range, pts patients
BΝ^ indicates that the values are not normally distributed, based on the Shapiro-Wilk test
aMann–Whitney U test was usedb Fisher’s exact test was used
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In our cohort, taking into consideration all initial patients
(273 THAs) until the time of last contact or death, there
were 0.19 revisions per 100 observed component years
(with a mean implantation time per THA of 7.9 years and
with revision for any reason as the endpoint), which is
outside the lower extremity of the 95 % CI documented
by Janda et al. The survival performance of this novel
system is therefore in line with or exceeds that documented
for the original system.
Regarding patients outcomes, the median HHS in our se-
ries was 99.9 (mean 97.4) at a median follow-up of 9.3 years
(mean, 9.3 years), with no significant differences between
CoC and CoPE articulations. In the reviewed literature, two
studies documented the HHS at a follow-up time similar to
ours. Pieringer et al. [8] reported a median HHS of 89 (mean,
85.4) at a mean follow-up of 10.8 years, while Grübl et al. [7]
reported a mean HHS of 85.4 at a median follow-up of
10.1 years.
Despite the excellent Harris hip score results in our study
cohort, there were four intra-operative trochanteric fractures
(1.5 %), which are, however, not uncommon during the im-
plantation of standard-length stems through the direct lateral
surgical approach [21].
Radiolucent lines around the stem in at least one Gruen
zone were reported in 6.7 % of the hips that could be radio-
graphically assessed at final follow-up. This value is far lower
than that observed in previous studies with the original stem
[10, 22]. Stem geometry is known to influence post-operative
bone remodelling [23], and the lower incidence of radiolucent
lines in the proximal Gruen zones with the novel device may
indicate that the proximal macrostructure of the stem im-
proves proximal osseointegration. Nevertheless, the impact
of proximal radiolucent lines on longevity of Alloclassic
Zweymüller-type stems has been questioned—proximal fem-
oral radiolucent lines have, in fact, been described as clinically
irrelevant after observation periods of up to 17 years [10, 22].
Heterotopic ossification was documented in 23.6 % of
cases, with a significantly higher incidence in patients who
did not receive NSAIDs (p=0.010). This supports the litera-
ture indicating that NSAID administration helps to prevent
heterotopic ossification [24, 25].
The present study has some limitations, primarily the lack
of pre-operative HHS and the retrospective character of the
study design. However, as far as we are aware, this is the first
study to document eight- to ten-year results for THAs per-
formed with this relatively new system.
Table 3 Overview of the primary results documented in the present study and in published studies on the Alloclassic Zweymüller system reporting
ten-year Kaplan-Meier survival







Present study 273 Mean: 9.3±0.5
Median: 9.3
Range: 8.4 - 10.3





98.4 % 100 % 98.4 %




NR NR ~92 %




99 % ~99 % ~98 %
Zwartele et al. (2008) [12] 77 (RA)a
135 (OA)a
Mean: 12.5
Range: 10 – 17.5
NR NR NR ~92 % (RA)
~93 % (OA)





100 % ~97 % ~97 %




NR NR 95.8 %
Garcia-Cimbrelo et al. (2003) [6] 124 Mean: 11.3
Range: 10–13
NR NR NR 94.1 %





98.9 % NR NR
Grübl et al. (2002) [7] 208 Median: 10.1 Mean: 85.4
Range: 46–100
99 % 93 % 92 %
B~^ denotes that the approximate value was retrieved from the graph in the original publication
KM Kaplan-Meier, NR not reported, IQR interquartile range, pts patients
a Zwartele et al. [12] compared the results in patients suffering from rheumatoid arthritis (RA) with those in patients suffering from osteoarthritis (OA)
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In conclusion, eight- to ten-year outcomes for THAs per-
formed with the study system were in line with those docu-
mented for its predecessor.
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